4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
ADMINISTRATION OF BLOOD
Administration of Blood
Dr. Mukesh Desai
Consultant Pediatric Hematologist-H.N. Hospital,
Consultant Pediatric Hematologist-Nanavati Hospital.


Continued...

ADVERSE REACTIONS TO BLOOD TRANSFUSION :


Comparison of TAGvHD and GvHD in BMT :

TAGvHD
BMT GvHD
Incidence
0.1 to 1.0% 30 to 70%;
Onset
2-47 days 35 to 70 days
Pancytopenia
Frequent Rare
BM
Hypocellular not affected
Duration of illness
<54 days 5 months
Mortality
87- 100% 5 - 10%
PREVENTION:
Irradiation of blood and blood component for patients at risk. Dose: 2500
Irradiation of :
  •  Cellular component intrauterine transfusion
  •  Patients identified at risk for TAGvHD
  •  Transfusion of cellular component between blood relatives
  •  Transfusion of HLA selected products
  • MORTALITY: 87 TO 100%

    Anaphylactoid reaction to ACE inhibition.

    Reaction: flushing and hypotension in patients on ACE inhibitors

    Mechanism : Prekallikrein present in blood and blood product is converted to vasoactive bradykinin whose metabolism is inhibited by ACE inhibitors resulting in hypotension.

    Procedures associated:-Therapeutic plasma exchange with albumin replacement
    - Contact of plasma with dialysis membrane

    DELAYED HEMOLYTIC TRANSFUSION REACTION :

    Two types :
    -
    Anamnestic response to transfused RBCs
      - Primary alloimmunisation
    Incidence
     
    1 : 11000 to 1 : 5000
        0.05% to 0.07% of transfusion recipient
    Clinical presentation :
    -
    More common in multiply transfused & Multiparous women
      - Occurs 3 - 7 days post transfusion
      - Extravascular hemolysis
      - Absence of anticipated Hb or HCT rise following blood
      - Transfusion.
      - Jaundice
      - Fever
      - Rarely hemoglobinuria
       
    Antibodies implicated :
    Common antibodies
    Uncommon antibodies
    Anti jka
    Anti A1
    Anti E
    Anti P1
    Anti D
    Anti C
    Anti K
    Anti Fya
    Rarely Anti HLA antibodies
    Investigations :
     
    Freshly draw blood to test for alloantibodies,
        Compare with previous sample.
    Treatment:
    -
    Rarely necessary
      - Observe urine output
      - Blood transfusion that lack the corresponding antigen.
    Prevention:   Blood that lack the responsible antigen.
        Issue medical alert card to these patients
     
    Maintain record of the offending antibodies.

     
     
    Educational Section
     
    Disclaimer:
    The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
     
    copyright ©2011 website design & development by Levioza
    Follow Us
    Follow us on :
    Folllow Us